-
Sector Analysis
NewFuture of Pharma – Looking Ahead to 2024
This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors.
-
Thematic Analysis
NewPharma M&A Deals Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Pharma Sector
-
Product Insights
NewSleep Apnea Diagnostic Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Sleep Apnea Diagnostic Systems Pipeline Market Report Overview Sleep Apnea Diagnostic Systems include polysomnography systems (PSG systems) used for the screening of sleep apnea. These include systems and devices used for the diagnosis of sleep apnea. One PSG system includes amplifiers, a hard disk, a monitor, a recorder, a laser printer, electrodes, cables, stands, stimulators, chest and abdomen respiration belts, and sensors. Fixed and portable polysomnography systems are tracked under this category. The Sleep Apnea Diagnostic Systems pipeline market report...
-
Sector Analysis
NewUnited Kingdom (UK) Apparel Market Size and Trend Analysis by Category, Retail Channel, Consumer Attitudes, Brands and Forecast to 2028
UK Apparel Market Report Overview The UK apparel market size was valued at GBP60.7 billion in 2023. The market will witness slow growth at a CAGR of more than 1% during 2023-2028 as consumers will retain a cautious approach to spending, while resale channels and capsule wardrobes will also remain popular. The UK apparel market report offers data that showcase the trends in the market and sectors by value and volume. It also reveals the brand leaders by market share...
-
Sector Analysis
NewQatar Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Qatar Defense Market Report Overview In 2024, Qatar's defense budget is worth $14.4 billion. The country’s defense budget will grow at a CAGR of more than 6% during 2025-2029. The arms race in the Middle East region, modernization initiatives, the threat of Iranian missiles, and Qatar's diplomatic disputes are driving arms procurement in the country. Additionally, Qatar is spending billions of dollars to increase its military power, especially its air force capabilities. Amidst the ongoing diplomatic crisis, the country had...
-
Product Insights
NewSystemic Sclerosis (Scleroderma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Systemic Sclerosis (Scleroderma) Clinical Trial Report Overview A total of 683 systemic sclerosis clinical trials were conducted as of April 2024. The systemic sclerosis clinical trial report provides a comprehensive understanding of the systemic sclerosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·      North America...
-
Product Insights
NewChronic Lymphocytic Leukemia (CLL) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Chronic Lymphocytic Leukemia (CLL) Clinical Trial Report Overview A total of 2311 CLL clinical trials were conducted as of April 2024. The CLL clinical trial report provides a comprehensive understanding of the CLL clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·      North America ·      Europe...
-
Product Insights
NewHospital Acquired Pneumonia (HAP) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Hospital Acquired Pneumonia (HAP) Clinical Trial Report Overview A total of 581 HAP clinical trials were conducted as of April 2024. The HAP clinical trial report provides a comprehensive understanding of the HAP clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·      North America ·      Europe...
-
Sector Analysis
NewNuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Nuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area. The model discusses in detail the impact of COVID-19 on Nuclear Imaging Agents market for the year 2020 and beyond. Nuclear Imaging is a noninvasive medical technique which uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases. The diseases include cancers, cardiac diseases, gastrointestinal, endocrine and neurological diseases. Nuclear...